Search
Altropane I-123
go.drugbank.com/drugs/DB15144InvestigationalAltropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the
Clofoctol
go.drugbank.com/drugs/DB13237ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseChlormidazole
go.drugbank.com/drugs/DB13611ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseCarbuterol
go.drugbank.com/drugs/DB13625ExperimentalCategories: Adrenergics for Systemic Use, Drugs for Obstructive Airway DiseasesSulfathiourea
go.drugbank.com/drugs/DB13699ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseNovaferon
go.drugbank.com/drugs/DB16483InvestigationalCategories: Experimental Unapproved Treatments for COVID-19OS2966
go.drugbank.com/drugs/DB17207InvestigationalOS2966 is a humanized integrin β1 (CD29) blocking antibody currently evaluated for the treatment of acute myeloid leukemia, glioblastoma and ovarian cancer.[A254561, L47351]
AUM-601
go.drugbank.com/drugs/DB17382ExperimentalIt is currently being investigated in clinical trials for the treatment of cancer.
F6-734
go.drugbank.com/drugs/DB17444ExperimentalF6-734 is a bispecific monoclonal antibody with affinity for anticarcinoembryonic antigen (CEA) and anti-diethylenetriamine pentaacetic acid (DTPA) (hMN-14 × m734).[A255217,A255222]
CB-010
go.drugbank.com/drugs/DB17711InvestigationalCB-010 is a CRISPR-edited allogeneic CAR-T cell therapy targeting CD19. It is being investigated for the treatment of follicular lymphoma.[L46158]